JPMorgan financial advisers say that they were encouraged to push the firm’s proprietary products despite the availability of less expensive, better performing alternatives, and that the firm exaggerated the returns of at least one crucial offering (See “Former Brokers Say JPMorgan Favored Selling Banks’ Own Funds Over Others,” by Susanne Craig and Jessica Silver-Greenberg).